posted
SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (OTC Bulletin Board: NAWL - News), an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products, announced today its preliminary unaudited March 2007 sales results on a stand alone basis. Revenue in March 2007 was $34,296, an increase of $32,419 or 1,727% over March 2006 results.
In addition, for the three months ended March 31, 2007, NatureWell's revenue was $97,056 compared to $8,247 for the three months ended March 31, 2006. This represents an increase of $88,809 or approximately 1,077%. For the nine months ended March 31, 2007, NatureWell's revenue was $152,070 compared to $35,447 for the nine months ended March 31, 2006. This represents an increase of $116,623 or approximately 329%.
"Our fiscal third quarter ended March 31, 2007 was very encouraging as we continued our transition from a research and development company into an emerging sales and marketing entity," commented NatureWell, Incorporated's Chairman and Chief Executive Officer, James R. Arabia. "Some of the highlights in the fiscal third quarter included total revenue growth of nearly 1,100%; becoming an Authorized Vendor of Chiropractors Buying Group, Inc.; the implementation of several sales initiatives, including an expanded outbound tele-sales program; and attendance and presentation at industry trade shows and events."
Posts: 1364 | From: Somebody from Europe | Registered: Sep 2005
| IP: Logged |
"As of February 9, 2007 the Company had issued and outstanding 376,244,030."
Posts: 1364 | From: Somebody from Europe | Registered: Sep 2005
| IP: Logged |
quote:Originally posted by matto: I am talking about the stock going upto it's resistant point of .003. So it has the potential to make it from .0017 to .003 or .0035.
LOL, sorry i misread your post. My fault. Moving premarket. Looking good.
posted
Didnt get filled at .0018 ... too high now for me with low volume... will watch it for a while... Would have been a gr8 buy at .0018
Posts: 1101 | From: Georgia | Registered: Apr 2006
| IP: Logged |
posted
Rats.... wish I had gotten in at the .0018 well sometimes your the bug and sometimes your the windshield.... to day i am the BUG Posts: 1101 | From: Georgia | Registered: Apr 2006
| IP: Logged |
posted
I usually wont put in a bid higher that the close but I did on this one really thought it was a winner for today... it just moved to fast i guess for AMTRD to let me get in on it.... Good luck guys Posts: 1101 | From: Georgia | Registered: Apr 2006
| IP: Logged |
posted
NatureWell April Revenue Up 954 Percent May 14, 2007 7:00:00 AM
SAN DIEGO, CA -- (MARKET WIRE) -- 05/14/07 -- NatureWell, Incorporated (OTCBB: NAWL), an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products, announced today its preliminary unaudited April 2007 sales results on a stand alone basis.
Revenue in April 2007 was $50,080 compared to $4,752 in April 2006. This represents an increase of $45,328 or 954%. For the ten months ended April 30, 2007, NatureWell's revenue was $202,150 compared to $40,199 for the ten months ended March 31, 2006. This represents an increase of $161,951 or approximately 403%.
"I'm pleased with our April sales numbers," commented NatureWell, Incorporated's Chairman and Chief Executive Officer, James R. Arabia. "Our sales and customer service representatives continue to open practitioner accounts and raise awareness about MigraSpray through our out-bound telemarketing efforts. We will continue that effort as we explore ways to expand it."
About NatureWell, Incorporated:
NatureWell, Incorporated (www.naturewell.com) is an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products. The Company's flagship product, MigraSpray (www.migraspray.com), is a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the "safe harbor" provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. These and other potential risks and uncertainties are set forth in the Company's filings with the Securities & Exchange Commission. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
Contact: James Arabia (619) 234-0222
Posts: 2473 | Registered: May 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Frown]](frown.gif)
![[Wink]](wink.gif)
